Optibrium, Imperial College and DNDi Collaborate in Drug Development Programme for Neglected Diseases

Product News   May 30, 2017 | Original story from Optibrium

 
Optibrium, Imperial College and DNDi Collaborate in Drug Development Programme for Neglected Diseases
 
 
FURTHER INFORMATION
 
 
 

Related Product News

ACD/Labs Announces Updates to its Spectrus Informatics Platform

Product News

V2017.1 release of ACD/Spectrus software introduces an innovative solution for impurity data management and exciting developments for deconvolution and analysis of mixtures.

READ MORE

Desktop Genetics Introduces New Series of Customizable CRISPR Libraries

Product News

DESKGEN Series Libraries are designed and manufactured using the latest CRISPR gene editing techniques and artificial intelligence to deliver a tailored end-to-end solution.

READ MORE

Expanding Applications for Temperature/Humidity Controlled Stability Chambers

Product News

SP Scientific Hotpack Stability Chambers offer precision temperature and humidity control.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE